Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

The board of ISTA Pharmaceuticals (ISTA +68.1%) confirms that it rejected Valeant...

  • Friday, December 16, 2011, 11:09 AM ET
    The board of ISTA Pharmaceuticals (ISTA +68.1%) confirms that it rejected Valeant Pharmaceuticals' (VRX -0.5%) offer of $6.50/share, calling it "grossly inadequate."
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »